Share

August 21, 2012; 79 (8) Articles

Obesity phenotypes in midlife and cognition in early old age

The Whitehall II cohort study

Archana Singh-Manoux, Sébastien Czernichow, Alexis Elbaz, Aline Dugravot, Séverine Sabia, Gareth Hagger-Johnson, Sara Kaffashian, Marie Zins, Eric J. Brunner, Hermann Nabi, Mika Kivimäki
First published August 20, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182661f63
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
867

Share

Article Information

vol. 79 no. 8 755-762
DOI: 
https://doi.org/10.1212/WNL.0b013e3182661f63
PubMed: 
22915175
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received December 20, 2011
  • Accepted April 10, 2012
  • First Published August 20, 2012.
Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Archana Singh-Manoux, PhD,
    2. Sébastien Czernichow, MD, PhD,
    3. Alexis Elbaz, MD, PhD,
    4. Aline Dugravot, MSc,
    5. Séverine Sabia, PhD,
    6. Gareth Hagger-Johnson, PhD,
    7. Sara Kaffashian, MSc,
    8. Marie Zins, MD, PhD,
    9. Eric J. Brunner, PhD,
    10. Hermann Nabi, PhD and
    11. Mika Kivimäki, PhD
  1. Archana Singh-Manoux, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Epidemiology & Community Health (Associate Editor, since 2011)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. MRC UK G10011354, Co-I, 2011-2015; French Institute for Research on Public Health, PI, 2011-2014; NIH/NIA R01AG013196, PI, 2009-2014; NIH/NIA R01AG034454, PI, 2009-2014; MRC UK G0902037, Co-I, 2010-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sébastien Czernichow, MD, PhD,
    3. Scientific Advisory Boards:

    1. 1)SANOFI 2) Unilever

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Travel to the European Diabetes Meeting: SERVIER

    Editorial Boards:

    1. 1) European Journal of Preventive Cardiology, board of editor, since 2011 2) Obesité, journal editor, since 2011 3) Cahiers de Nutrition et Diététique, board member, since 2007

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1) SANOFI 2) Unilever 3) EFFIK

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) French Ministry of Health, Grant PHRC, 2011, principal investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Alexis Elbaz, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Agence nationale de la recherche (France) - IGE-MP (2010-2012)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Aline Dugravot, MSc,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Séverine Sabia, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. I am supported by a grant from the National Institute on Aging, NIH (R01AG034454).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Gareth Hagger-Johnson, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Introduction to Research Methods and Data Analysis in Psychology, Pearson Prentice Hall, 2009 (receipt of royalties biannually since publication).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Sara Kaffashian, MSc,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Marie Zins, MD, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Inserm TGIR Cohortes, PI, 2010-2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Eric J. Brunner, PhD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Hermann Nabi, PhD and
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Mika Kivimäki, PhD
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHLBI R01HL036310 [PI], NIA R01AG034454 [PI], the British MRC (G0902037 [co-I]

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From INSERM, U1018, Center for Research in Epidemiology and Population Health (A.S.-M., S.C., A.D., S.K., M.Z., H.N.), Hôpital Paul Brousse, Villejuif, France; Department of Epidemiology and Public Health (A.S.-M., S.S., G.H.-J., E.J.B., M.K.), University College London, UK; Centre de Gérontologie (A.S.-M.), Hôpital Ste Périne, AP-HP, Paris, France; University Versailles St-Quentin (A.S.-M., S.C., A.D., M.Z.), Boulogne-Billancourt, France; Department of Nutrition (S.C.), Ambroise Paré Hospital, Boulogne-Billancourt, France; INSERM, U708 (A.E.), F-75013, Paris, France; and UPMC Paris 06, UMR_S 708 (A.E.), F-75005, Paris, France.
  1. Correspondence & reprint requests to Dr. Singh-Manoux: archana.singh-manoux{at}inserm.fr
View Full Text

Article usage

Article usage: August 2012 to February 2023

AbstractFullPdfSource
Aug 2012511571178Highwire
Sep 201218334654Highwire
Oct 201212542937Highwire
Nov 20124631216Highwire
Dec 2012401713Highwire
Jan 20134072315Highwire
Feb 201332464Highwire
Mar 201329487Highwire
Apr 201324963Highwire
May 201322112Highwire
Jun 201331556Highwire
Jul 201325743Highwire
Aug 201322703Highwire
Sep 201328419Highwire
Oct 2013234910Highwire
Nov 201322406Highwire
Dec 201317600Highwire
Jan 201421925Highwire
Jan 201401812pmc
Feb 201421565Highwire
Mar 201422613Highwire
Apr 201425512Highwire
May 201419023Highwire
Jun 201418232Highwire
Jul 201415911Highwire
Aug 201420543Highwire
Sep 201421622Highwire
Oct 201418254Highwire
Nov 201419021Highwire
Dec 201419311Highwire
Jan 201520401Highwire
Jan 201501915pmc
Feb 201519410Highwire
Feb 201502211pmc
Mar 201519200Highwire
Mar 20150125pmc
Apr 201515230Highwire
Apr 20150114pmc
May 201521223Highwire
May 20150177pmc
Jun 201545912Highwire
Jun 201501712pmc
Jul 201521111Highwire
Jul 2015085pmc
Aug 201518931Highwire
Aug 2015087pmc
Sep 201525834Highwire
Sep 201501916pmc
Oct 201517821Highwire
Oct 201502215pmc
Nov 201516000Highwire
Nov 2015098pmc
Dec 201523200Highwire
Dec 2015097pmc
Jan 201616111Highwire
Jan 201601214pmc
Feb 201611410Highwire
Feb 201601310pmc
Mar 201628011Highwire
Mar 20160217pmc
Apr 201617000Highwire
Apr 20160223pmc
May 201617201Highwire
May 2016075pmc
Jun 201614121Highwire
Jun 2016075pmc
Jul 201613800Highwire
Jul 20160179pmc
Aug 201618521Highwire
Aug 2016062pmc
Sep 201615012Highwire
Sep 20160134pmc
Oct 201615700Highwire
Oct 20160117pmc
Nov 201615000Highwire
Nov 20160115pmc
Dec 201610800Highwire
Dec 20160133pmc
Jan 201712700Highwire
Jan 201701513pmc
Feb 20177300Highwire
Feb 2017074pmc
Mar 201722300Highwire
Mar 201705524pmc
Apr 201710200Highwire
Apr 201742832pmc
May 201710400Highwire
May 2017102838pmc
Jun 20177200Highwire
Jun 2017045pmc
Jul 20178821Highwire
Jul 201761320pmc
Aug 20178900Highwire
Aug 201741214pmc
Sep 20179401Highwire
Sep 201721010pmc
Oct 20179200Highwire
Oct 20173910pmc
Nov 201710501Highwire
Nov 2017256pmc
Dec 20179000Highwire
Jan 20189621Highwire
Feb 201810610Highwire
Mar 201831810Highwire
Apr 201814722Highwire
Apr 201851213pmc
May 201811001Highwire
Jun 20188901Highwire
Jun 2018078pmc
Jul 20189700Highwire
Aug 20187910Highwire
Aug 2018477pmc
Sep 20186610Highwire
Oct 20188600Highwire
Nov 201810720Highwire
Dec 201811000Highwire
Jan 201915111Highwire
Feb 201914530Highwire
Mar 20199804Highwire
Apr 20199401Highwire
May 201911600Highwire
Jun 20199722Highwire
Jul 20199221Highwire
Aug 201910800Highwire
Sep 20199201Highwire
Oct 201921103Highwire
Nov 201911500Highwire
Dec 201911001Highwire
Jan 20208804Highwire
Feb 20208400Highwire
Mar 20209900Highwire
Apr 20206002Highwire
May 20205612Highwire
Jun 20205300Highwire
Jul 20207800Highwire
Aug 20205400Highwire
Sep 20209301Highwire
Oct 20206100Highwire
Nov 202010610Highwire
Dec 202010400Highwire
Jan 20219000Highwire
Feb 20217500Highwire
Mar 20219910Highwire
Apr 202112500Highwire
May 20219810Highwire
Jun 20216011Highwire
Jul 20219600Highwire
Aug 20217810Highwire
Sep 20218902Highwire
Oct 20216701Highwire
Nov 20218900Highwire
Dec 20219700Highwire
Jan 202212723Highwire
Feb 202211300Highwire
Mar 202210700Highwire
Apr 20228600Highwire
May 20228600Highwire
Jun 202210800Highwire
Jul 202211611Highwire
Aug 20229001Highwire
Sep 202210522Highwire
Oct 20228503Highwire
Nov 202213211Highwire
Dec 202211300Highwire
Jan 202313600Highwire
Feb 20239711Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles